The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CALGB (Alliance) 40603: Long-term outcomes (LTOs) after neoadjuvant chemotherapy (NACT) +/- carboplatin (Cb) and bevacizumab (Bev) in triple-negative breast cancer (TNBC).
 
William M. Sikov
Honoraria - Celgene; Eisai
Consulting or Advisory Role - Abbvie; Celgene
 
Mei-Yin Polley
No Relationships to Disclose
 
Erin Twohy
No Relationships to Disclose
 
Charles M. Perou
Leadership - Bioclassifier; GeneCentric
Stock and Other Ownership Interests - Bioclassifier; GeneCentric
Consulting or Advisory Role - Bioclassifier; G1 Therapeutics; GeneCentric; Ions Pharmaceuticals
Patents, Royalties, Other Intellectual Property - royalties from PAM50 breast cancer gene patent application, and from lung gene signature patent
Travel, Accommodations, Expenses - Chugai Pharma; Takeda
 
Baljit Singh
No Relationships to Disclose
 
Donald A. Berry
Employment - Berry Consultants
Leadership - Berry Consultants
Stock and Other Ownership Interests - Berry Consultants
Consulting or Advisory Role - Berry Consultants
Travel, Accommodations, Expenses - Berry Consultants
 
Sara M. Tolaney
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Celldex; Eisai; Genentech; Immunomedics; Lilly; Merck; NanoString Technologies; Nektar; Novartis; Pfizer; Puma Biotechnology; Sanofi; Tesaro
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); NanoString Technologies (Inst); Nektar (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celldex; Eisai; Genentech/Roche; Immunomedics; Lilly; Merck; NanoString Technologies; Nektar; Novartis; Pfizer; Puma Biotechnology
 
George Somlo
Consulting or Advisory Role - Abbvie; AstraZeneca; Genentech/Roche; Pfizer; Takeda
Speakers' Bureau - Takeda
Research Funding - Agendia (Inst); Celgene (Inst); Roche/Genentech (Inst)
Other Relationship - Abbvie
 
Elisa R. Port
No Relationships to Disclose
 
Cynthia X. Ma
Consulting or Advisory Role - AstraZeneca; Biovica; Lilly; Merck; Novartis; Pfizer; Pfizer; Puma Biotechnology; Syndax; Tempus
Research Funding - Eisai (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Novartis; pfizer; Syndax
 
Charles S. Kuzma
No Relationships to Disclose
 
Eleftherios P. Mamounas
Honoraria - Genentech/Roche; Genomic Health
Consulting or Advisory Role - bioTheranostics; Genomic Health; Merck; Roche/Genentech
Speakers' Bureau - Genentech/Roche; Genomic Health
Travel, Accommodations, Expenses - Genentech/Roche; Genomic Health
 
Mehra Golshan
Consulting or Advisory Role - Abbvie
Research Funding - Breast Cancer Research Foundation
 
Jennifer Ruth Bellon
Honoraria - uptodate
 
Deborah E. Collyar
Honoraria - McKinsey & Company; MK&A; Quintiles; TrialScope, Inc.
Consulting or Advisory Role - M2Gen; Takeda
Travel, Accommodations, Expenses - Boehringer Ingelheim
Other Relationship - Kinapse
 
Olwen Mary Hahn
Leadership - Via Oncology
Honoraria - Cardinal Health (I)
Consulting or Advisory Role - Pfizer; Pfizer
Travel, Accommodations, Expenses - Cardinal Health (I)
 
Clifford A. Hudis
Leadership - Alliance Foundation Trials
Consulting or Advisory Role - Alliance Foundation Trials; Columbia University
Other Relationship - Breast Cancer Research Foundation
 
Eric P. Winer
Stock and Other Ownership Interests - Verastem
Honoraria - Carrick Therapeutics; Genentech/Roche; GlaxoSmithKline; InfiniteMD; Jounce Therapeutics; Jounce Therapeutics; Lilly; Tesaro
Consulting or Advisory Role - InfiniteMD; Leap Therapeutics
Research Funding - Genentech (Inst)
 
Ann H. Partridge
No Relationships to Disclose
 
Lisa A. Carey
Research Funding - Immunomedics (Inst); Innocrin Pharma (Inst); Syndax (Inst)
Patents, Royalties, Other Intellectual Property - Royalty-sharing agreement, investorship interest in licensed IP to startup company, Falcon Therapeutics, that is designing neural stem cell-based therapy for glioblastoma multiforme. (I)